Trial Profile
A phase II trial of CHS-131 in Non-alcoholic-steatohepatitis
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 23 Nov 2018
Price :
$35
*
At a glance
- Drugs Ibrigampar (Primary)
- Indications Non-alcoholic steatohepatitis
- Focus Therapeutic Use
- 23 Nov 2018 New trial record